These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33043486)

  • 1. Feasibility and efficacy of low-dose pegfilgrastim for CD34
    Goto H; Hidaka D; Yamamoto S; Hayasaka K; Michimata R; Kagawa I; Sunagoya K; Iijima H; Hayase E; Shiratori S; Okada K; Sugita J; Onozawa M; Hashimoto D; Kahata K; Fujimoto K; Endo T; Shimizu C; Teshima T;
    J Clin Apher; 2020 Sep; 35(5):413-419. PubMed ID: 33043486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.
    Bassi S; Rabascio C; Nassi L; Steffanoni S; Babic A; Bertazzoni P; Gigli F; Antoniotti P; Orlando L; Sammassimo S; Quarna J; Negri M; Martinelli G
    Transfus Apher Sci; 2010 Dec; 43(3):321-326. PubMed ID: 21036667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction.
    Abid MB; De Mel S; Abid MA; Yap ES; Gopalakrishnan SK; Chen Y; Yuen YC; Wong HC; Lin A; Poon LM; Koh LP; Chng WJ; Tan LK
    Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):174-179. PubMed ID: 29398647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Single-dose Pegfilgrastim for CD34 + Cell Mobilization in Healthy Volunteers: A Phase 2 Study.
    Goto H; Sugita J; Hasegawa Y; Hayasaka K; Sunagoya K; Hatase R; Nishida M; Ichihashi Y; Odera M; Senjo H; Yokoyama S; Ara T; Shiratori S; Endo T; Hino M; Maeda Y; Sawa M; Sato N; Teshima T
    Transplantation; 2024 Apr; 108(4):996-1003. PubMed ID: 38012835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
    Kroschinsky F; Hölig K; Ehninger G
    Transfus Apher Sci; 2008 Jun; 38(3):237-44. PubMed ID: 18490197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double blind control trial comparing filgrastim and pegfilgrastim in cyclophosphamide peripheral blood hematopoietic stem cell mobilization.
    Kuan JW; Su AT; Wong SP; Sim XY; Toh SG; Ong TC; Rajasuriarr JS; Lim SH; Guan YK; Liew HK; Liew PK; Tan JT; Kori AN; Cheng YY; Tan SM; Chang KM
    Transfus Apher Sci; 2015 Oct; 53(2):196-204. PubMed ID: 25910537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Kroschinsky F; Hölig K; Platzbecker U; Poppe-Thiede K; Ordemann R; Blechschmidt M; Oelschlaegel U; Schaich M; Hänel M; Bornhäuser M; Ehninger G
    Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Steidl U; Fenk R; Bruns I; Neumann F; Kondakci M; Hoyer B; Gräf T; Rohr UP; Bork S; Kronenwett R; Haas R; Kobbe G
    Bone Marrow Transplant; 2005 Jan; 35(1):33-6. PubMed ID: 15531906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
    Isidori A; Tani M; Bonifazi F; Zinzani P; Curti A; Motta MR; Rizzi S; Giudice V; Farese O; Rovito M; Alinari L; Conte R; Baccarani M; Lemoli RM
    Haematologica; 2005 Feb; 90(2):225-31. PubMed ID: 15710576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful peripheral blood stem cell mobilization using pegfilgrastim in allogeneic stem cell transplantation.
    Chanswangphuwana C; Kupatawintu P; Panjai P; Tunsittipun P; Intragumtornchai T; Bunworasate U
    Int J Hematol; 2014 Mar; 99(3):318-22. PubMed ID: 24474639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial.
    Herbert KE; Demosthenous L; Wiesner G; Link E; Westerman DA; Came N; Ritchie DS; Harrison S; Seymour JF; Prince HM
    Bone Marrow Transplant; 2014 Aug; 49(8):1056-62. PubMed ID: 24887382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
    Russell N; Mesters R; Schubert J; Boogaerts M; Johnsen HE; Canizo CD; Baker N; Barker P; Skacel T; Schmitz N
    Haematologica; 2008 Mar; 93(3):405-12. PubMed ID: 18268285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and kinetics of CD34
    Takhar H; Mislang AR; Singhal N; Brown MP
    Asia Pac J Clin Oncol; 2017 Feb; 13(1):79-86. PubMed ID: 27649817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Fruehauf S; Klaus J; Huesing J; Veldwijk MR; Buss EC; Topaly J; Seeger T; Zeller LW; Moehler T; Ho AD; Goldschmidt H
    Bone Marrow Transplant; 2007 Jun; 39(12):743-50. PubMed ID: 17450182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta-analysis.
    Kuan JW; Su AT; Leong CF
    J Clin Apher; 2017 Dec; 32(6):517-542. PubMed ID: 28485020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34
    Partanen A; Turunen A; Valtola J; Vasala K; Ågren L; Penttilä K; Pyörälä M; Kuittinen T; Mäntymaa P; Pelkonen J; Jantunen E; Varmavuo V
    J Clin Apher; 2020 Aug; 35(4):255-263. PubMed ID: 32311780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells.
    Herbert KE; Gambell P; Link EK; Mouminoglu A; Wall DM; Harrison SJ; Ritchie DS; Seymour JF; Prince HM
    Bone Marrow Transplant; 2013 Mar; 48(3):351-6. PubMed ID: 22858510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of peripheral blood stem cell mobilization with filgrastim versus pegfilgrastim in lymphoma patients - single center experience.
    Lipan L; Colita A; Stefan L; Calugaroiu C; Serban C; Tomuleasa C; Pasca S; Colita A; Tanase A
    J BUON; 2021; 26(3):1080-1087. PubMed ID: 34268975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.